Abstract
OBJECTIVE: To determine the geographic variability of Medicaid acceptance among allergists in the US. STUDY DESIGN: Geospatial analysis predicted Medicaid acceptance across space, and a multivariable regression identified area-level population demographic variables associated with acceptance. METHODS: We used the National Plan & Provider Enumeration System database to identify allergists. Medicaid acceptance was determined from lists or search engines from state Medicaid offices and calls to provider offices. Spatial analysis was performed using the empirical Bayesian kriging tool. Multivariate logistic regression was used to identify county-level characteristics associated with provider Medicaid acceptance. RESULTS: Of 5694 allergists, 55.5% accepted Medicaid. Acceptance in each state ranged from 13% to 90%. Washington, Arizona, and the Northeast had lowest predicted proportion of both Medicaid acceptance and Medicaid acceptance per 10,000 enrollees. Overall, county-level characteristics were not associated with the likelihood of accepting Medicaid in multivariate analyses. Only the percentage of individuals living in poverty was associated with a higher likelihood of providers accepting Medicaid (OR, 1.245; 95% CI, 1.156-1.340; P < .001). CONCLUSIONS: A barrier to accessing allergy-related health care is finding a provider who accepts a patient’s insurance, which is largely variable by state. Lack of access to allergy care likely affects health outcomes for children with prevalent atopic conditions such as food allergy.
Original language | English (US) |
---|---|
Pages (from-to) | 374-379 |
Number of pages | 6 |
Journal | American Journal of Managed Care |
Volume | 30 |
Issue number | 8 |
DOIs | |
State | Published - Aug 2024 |
Funding
Author Disclosures: Dr Nimmagadda receives research grant support from the National Institutes of Health and Food Allergy Research and Education (FARE). Dr Gupta reports serving as a medical consultant/advisor for Genentech, Novartis, Aimmune LLC, Allergenis LLC, and FARE; receiving research support from the National Institutes of Health (R21 ID #AI135705, R01 ID #AI130348, U01 ID #AI138907), FARE, Sunshine Charitable Foundation, Novartis, and Genentech; and having an ownership interest in Yobee Care Inc. Dr Bilaver receives research grant support from the National Institutes of Health, Thermo Fisher Scientific, FARE, Genentech, National Confectioners Association, Novartis, Yobee Care Inc, and Before Brands Inc. The remaining authors report no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this article.
ASJC Scopus subject areas
- Health Policy